Revvity, Inc. (NYSE: RVTY) announced that its Revvity Signals Software business is launching Signals BioDesignTM, a ...

Zhang, J., Zhai, L., Sun, J.D., Yang, C.C., Zhang, Y., Sun, Y.N., Wu, Z.J. and Luo, H.J. (2026) Effect of Glycine Betaine on ...

A Foundation of Scientific Integrity: The CAS Pedigree The primary differentiator for Labor in a crowded global market is its “Research-First” DNA. Born from the Beijing Branch of the Chinese Academy ...

Drug Discovery Software Market OverviewThe global drug discovery software market is emerging as a high-impact segment within the life sciences technology ecosystem, driven by the urgent need for ...

How can enterprise devops teams improve the resiliency of their mission-critical apps, integrations, and data pipelines? Look ...

After firing people under the guise of AI efficiency, companies are now using AI to augment human talent rather than displace ...

This article traces the history of high-throughput screening (HTS), describes key technological milestones, and examines the ...

Background Neutrophils guarantee a prompt and robust host response to pathogens. Yet, overshooting neutrophil activation ...

Agentic AI is ushering in a new era for enterprises, moving beyond reactive LLMs to intelligent systems that plan, reason, ...

The market misinterprets past COVID-era revenue growth for 10x Genomics and fails to integrate current sector growth. Read why TXG stock is a Buy.

Stanford Medicine researchers have built CRISPR-GPT, a large language model designed to automate the full arc of gene-editing experiments, from selecting the right CRISPR system to designing guide ...

The next era in healthcare innovation is edge intelligence: running AI at the point of care, where data is generated and acted upon in real time.